Doravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) primarily indicated for the treatment of HIV-1 infection, where it functions by binding to the viral reverse transcriptase enzyme… Read more
Doravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) primarily indicated for the treatment of HIV-1 infection, where it functions by binding to the viral reverse transcriptase enzyme to block viral replication. This category provides access to high-quality reference standards for Doravirine, including the active pharmaceutical ingredient and a comprehensive range of related compounds essential for rigorous analytical testing. Pharmaceutical laboratories utilize these materials, which encompass process-related impurities such as the pyridinone, amide, and carboxylic acid derivatives, as well as N1-nitroso forms, to conduct accurate impurity profiling and method validation. Furthermore, stable isotope labelled compounds, including 13C and deuterium-labelled versions, are available to serve as internal standards in mass spectrometry-based assays. These reference materials support precise quality control protocols, ensuring that drug substances meet the strict specifications required for therapeutic safety and regulatory compliance.